454 related articles for article (PubMed ID: 10804326)
1. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
Oskarsson PR; Lins PE; Backman L; Adamson UC
Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
[TBL] [Abstract][Full Text] [Related]
2. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
[TBL] [Abstract][Full Text] [Related]
3. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
Hvidberg A; Christensen NJ; Hilsted J
Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
[TBL] [Abstract][Full Text] [Related]
4. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
5. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
Lunetta M; Di Mauro M; Le Moli R; Nicoletti F
Diabetes Metab; 1997 Dec; 23(6):524-7. PubMed ID: 9496559
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion.
Oskarsson PR; Lins PE; Wallberg Henriksson H; Adamson UC
Diabetes Metab; 1999 Dec; 25(6):491-7. PubMed ID: 10633873
[TBL] [Abstract][Full Text] [Related]
7. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
Wredling R; Liu D; Lins PE; Adamson U
Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
[TBL] [Abstract][Full Text] [Related]
8. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
[TBL] [Abstract][Full Text] [Related]
9. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
[TBL] [Abstract][Full Text] [Related]
10. Effects of C-peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients.
Oskarsson P; Johansson BL; Adamson U; Lins PE
Diabet Med; 1997 Aug; 14(8):655-9. PubMed ID: 9272591
[TBL] [Abstract][Full Text] [Related]
11. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
[TBL] [Abstract][Full Text] [Related]
12. Near normalization of metabolism of IDDM: comparison of continuous subcutaneous (CSII) versus intraperitoneal (CIPII) insulin delivery.
Gooch BR; Abumrad NN; Robinson RP; Crofford OB
Horm Metab Res; 1984 Dec; 16 Suppl 1():190-4. PubMed ID: 6398261
[TBL] [Abstract][Full Text] [Related]
13. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
14. Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes.
Ross LA; Warren RE; Kelnar CJ; Frier BM
Arch Dis Child; 2005 Feb; 90(2):190-4. PubMed ID: 15665180
[TBL] [Abstract][Full Text] [Related]
15. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
16. Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study.
Brock Jacobsen I; Vind BF; Korsholm L; Flyvbjerg A; Frystyk J; Holst JJ; Beck-Nielsen H; Henriksen JE
Acta Physiol (Oxf); 2011 Jul; 202(3):337-47. PubMed ID: 21481195
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
18. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
19. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
